Eli Lilly and Company

METiS TechBio signs $1.1B AI drug-delivery deal with Eli Lilly

METiS TechBio and Eli Lilly will develop tissue-targeted RNA delivery systems in a collaboration carrying up to about $1.1 billion in milestones.